Related Experiment Video
Updated: Dec 24, 2025

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Congenital diabetes mellitus
Dario Iafusco1, Angela Zanfardino2, Riccardo Bonfanti3
1Department of Pediatrics, University of Campania "Luigi Vanvitelli", Naples, Italy - dario.iafusco@unicampania.it.
Insights
Congenital diabetes mellitus, diagnosed before six months of life, presents as transient or permanent forms. Genetic discoveries enable targeted therapies, improving quality of life and potentially reducing complications compared to type 1 diabetes.
Area of Science:
- Pediatrics
- Endocrinology
- Genetics
Background:
- Congenital diabetes mellitus is a rare condition with hyperglycemia onset shortly after birth.
- It is classified as transient (TNDM) or permanent (PNDM), with equal prevalence.
- Clinical features include intrauterine growth retardation, dehydration, and potential associated anomalies.
Purpose of the Study:
- To review the causes, genes, and syndromes associated with congenital diabetes.
- To highlight advancements in understanding pathogenesis and pharmacogenetics.
- To compare congenital diabetes with type 1 diabetes in children.
Main Methods:
- Literature review of congenital diabetes mellitus.
- Analysis of genetic and syndromic causes.
- Examination of therapeutic approaches and clinical outcomes.
Main Results:
- Identified genetic alterations in pancreatic beta-cell potassium channels.
- Demonstrated improved quality of life with oral glibenclamide in specific forms.
- Observed a lower frequency of chronic complications compared to type 1 diabetes.
Conclusions:
- Understanding pathogenesis allows for tailored therapies, such as glibenclamide for potassium channel defects.
- Congenital diabetes offers unique treatment possibilities and a potentially better long-term outlook than autoimmune diabetes.
- Further research in pathogenesis and pharmacogenetics is crucial for this rare condition.
Abstract:
Congenital diabetes mellitus is a rare disorder characterized by hyperglycemia that occurs shortly after birth. We define "Diabetes of Infancy" if hyperglycemia onset before 6 months of life. From the clinical point of view, we distinguish two main types of diabetes of infancy: transient (TNDM), which remits spontaneously, and permanent (PNDM), which requires lifelong treatment. TNDM may relapse later in life. About 50% of cases are transient (TNDM) and 50% permanent. Clinical manifestations include severe intrauterine growth retardation, hyperglycemia and dehydration. A wide range of different associated clinical signs including facial dysmorphism, deafness and neurological, cardiac, kidney or urinary tract anomalies are reported. Developmental delay and learning difficulties may also be observed. In this paper we review all the causes of congenital diabetes and all genes and syndromes involved in this pathology. The discovery of the pathogenesis of most forms of congenital diabetes has made it possible to adapt the therapy to the diagnosis and in the forms of alteration of the potassium channels of the pancreatic Beta cells the switch from insulin to glibenclamide per os has greatly improved the quality of life. Congenital diabetes, although it is a very rare form, has been at the must of research in recent years especially for pathogenesis and pharmacogenetics. The most striking difference compared to the more frequent autoimmune diabetes in children (type 1 diabetes) is the possibility of treatment with hypoglycemic agents and the apparent lower frequency of chronic complications.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

